227 related articles for article (PubMed ID: 17086105)
1. Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model.
Garcia-Alloza M; Dodwell SA; Meyer-Luehmann M; Hyman BT; Bacskai BJ
J Neuropathol Exp Neurol; 2006 Nov; 65(11):1082-9. PubMed ID: 17086105
[TBL] [Abstract][Full Text] [Related]
2. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.
Garcia-Alloza M; Borrelli LA; Rozkalne A; Hyman BT; Bacskai BJ
J Neurochem; 2007 Aug; 102(4):1095-104. PubMed ID: 17472706
[TBL] [Abstract][Full Text] [Related]
3. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease.
Resende R; Moreira PI; Proença T; Deshpande A; Busciglio J; Pereira C; Oliveira CR
Free Radic Biol Med; 2008 Jun; 44(12):2051-7. PubMed ID: 18423383
[TBL] [Abstract][Full Text] [Related]
4. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress.
Lee KW; Kim JB; Seo JS; Kim TK; Im JY; Baek IS; Kim KS; Lee JK; Han PL
J Neurochem; 2009 Jan; 108(1):165-75. PubMed ID: 19012747
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
6. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
[TBL] [Abstract][Full Text] [Related]
7. Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice.
Garcia-Alloza M; Borrelli LA; Hyman BT; Bacskai BJ
Neurobiol Aging; 2010 Dec; 31(12):2058-68. PubMed ID: 19124175
[TBL] [Abstract][Full Text] [Related]
8. Involvement of oxidative stress in Alzheimer disease.
Nunomura A; Castellani RJ; Zhu X; Moreira PI; Perry G; Smith MA
J Neuropathol Exp Neurol; 2006 Jul; 65(7):631-41. PubMed ID: 16825950
[TBL] [Abstract][Full Text] [Related]
9. Dystrophic neurites in TgCRND8 and Tg2576 mice mimic human pathological brain aging.
Woodhouse A; Vickers JC; Adlard PA; Dickson TC
Neurobiol Aging; 2009 Jun; 30(6):864-74. PubMed ID: 17950493
[TBL] [Abstract][Full Text] [Related]
10. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
Melo JB; Sousa C; Garção P; Oliveira CR; Agostinho P
Eur J Neurosci; 2009 Feb; 29(3):455-64. PubMed ID: 19222556
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease.
Mohri I; Kadoyama K; Kanekiyo T; Sato Y; Kagitani-Shimono K; Saito Y; Suzuki K; Kudo T; Takeda M; Urade Y; Murayama S; Taniike M
J Neuropathol Exp Neurol; 2007 Jun; 66(6):469-80. PubMed ID: 17549007
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of amyloid plaque pathogenesis.
Fiala JC
Acta Neuropathol; 2007 Dec; 114(6):551-71. PubMed ID: 17805553
[TBL] [Abstract][Full Text] [Related]
14. In vivo multiphoton imaging of a transgenic mouse model of Alzheimer disease reveals marked thioflavine-S-associated alterations in neurite trajectories.
D'Amore JD; Kajdasz ST; McLellan ME; Bacskai BJ; Stern EA; Hyman BT
J Neuropathol Exp Neurol; 2003 Feb; 62(2):137-45. PubMed ID: 12578223
[TBL] [Abstract][Full Text] [Related]
15. Dietary zeolite supplementation reduces oxidative damage and plaque generation in the brain of an Alzheimer's disease mouse model.
Montinaro M; Uberti D; Maccarinelli G; Bonini SA; Ferrari-Toninelli G; Memo M
Life Sci; 2013 May; 92(17-19):903-10. PubMed ID: 23562853
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
17. The oxidative status of blood cells in a murine model of graft-versus-host disease.
Amer J; Weiss L; Reich S; Shapira MY; Slavin S; Fibach E
Ann Hematol; 2007 Oct; 86(10):753-8. PubMed ID: 17653715
[TBL] [Abstract][Full Text] [Related]
18. Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease.
Grutzendler J; Helmin K; Tsai J; Gan WB
Ann N Y Acad Sci; 2007 Feb; 1097():30-9. PubMed ID: 17413007
[TBL] [Abstract][Full Text] [Related]
19. Dystrophic neurites of senile plaques in Alzheimer's disease are deficient in cytochrome c oxidase.
Pérez-Gracia E; Torrejón-Escribano B; Ferrer I
Acta Neuropathol; 2008 Sep; 116(3):261-8. PubMed ID: 18629521
[TBL] [Abstract][Full Text] [Related]
20. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
